Revvity, ES-562-CF, cAMPZen Frozen Human Prostanoid EP2 Cell Line, HEK293 Cells

Prostanoid DP2 cAMPZen cells are validated frozen cells designed for high-throughput screening to identify drug candidates targeting the human Prostanoid DP2 receptor expressed in HEK293 host cells. The cAMPZen technology enables researchers to easily detect changes in cAMP levels as a direct indicator of receptor activation, making it valuable for tool for drug discovery. Each vial contains 2.5 million frozen cells validated for cAMP testing, providing a consistent and ready-to-use supply that streamlines workflows and accelerates drug discovery. The frozen format ensures reliable performance while maintaining cell viability. Please note that these cells are authorized for single-use only, and transfer, re-use, or propagation is not permitted under the product terms and conditions.